Skip to content

Seller review · costs and terms

altRx review

altRx publishes monthly product figures but leaves selected term and testing details unresolved. Its policy can make payment final before fulfillment, with a three-day cancellation window for future renewals.

By Jenna Pratt, consumer-access reporter · Updated October 2026

Itemized bill

altRx

Medicationconfirm quote
Bundled platform accessincluded
Bundled clinical reviewincluded
Listed product deliveryincluded
Patient laboratory servicesnot published

Totals are our arithmetic from the seller’s published figures. Extra fees unconfirmed: the seller states no amount for patient laboratory services. Confirm these charges and the medication price before paying.

The bill, in one line

Confirm the term, total payment and medical-disqualification deductions before paying. Cancel-anytime language stops future billing under the policy; it does not promise a refund of the purchased term.

The altRx policies describe a bundled subscription containing clinical, platform and appropriate pharmacy services, with independent OpenLoop professionals responsible for prescribing decisions. The selected package and purchase term determine what the buyer receives and which recurring charges can be stopped. They also settle what has already been purchased.

The product pages display compounded semaglutide at $89 per month and tirzepatide at $149, alongside a dashboard illustration showing a three-month subscription. That illustration does not conclusively establish the term qualifying for either headline, so confirm the actual collection and commitment before assuming an independent monthly purchase. Professional and platform components are bundled and product FAQs include delivery, while laboratory allowances can vary and still need confirmation for the chosen term.

Fees outside the headline

  • Bundled platform accessincluded

    The subscription terms include applicable platform-access fees in one total, not a separate zero-cost claim.

    Read October 2026

  • Bundled clinical reviewincluded

    The total subscription price includes applicable clinical services; the selected term still matters.

    Read October 2026

  • Listed product deliveryincluded

    The product FAQ explicitly includes shipping.

    Read October 2026

  • Patient laboratory servicesnot published

    The policy permits laboratory services where applicable without one universal patient allowance.

    Read October 2026

See altRx’s current price

Check the seller’s own page before you pay.

The fine print

Prepay
The refund policy covers single-month and multi-month plans, treating longer bundles as indivisible purchases without refunds for unused time or undelivered medicine. Having several available plan types does not identify which one qualifies for the headline, so confirm the applicable term before authorizing payment.
Cancellation
Contact patient support at least seventy-two hours before the next billing date; account cancellation may also be available under the selected arrangement. A request inside that window can leave another nonrefundable cycle payable, while stopping future renewal does not refund the current purchased term. Medical disqualification can permit a limited refund after deductions for used clinical review, prescription, laboratory or pharmacy services; it is not an unconditional full-refund promise. Ask how the company values those used components before payment, because that calculation can determine the amount returned when treatment cannot continue.
Shipping
Product FAQs include delivery, but the policy generally makes replacement the remedy for damaged or incorrect items and requires prompt reporting with evidence. FDA’s June 8, 2026 warning to Trinity HealthCare Supply, LLC dba altRx addresses misleading marketing and label identity for compounded semaglutide and tirzepatide. That record does not establish a defect in every shipment or an automatic refund right, and current disclaimers do not establish FDA closeout.

FDA warning letters

Worth it, and what to watch

Worth it

  • Bundled charge structure explained
  • Renewal notice window stated
  • Medical-disqualification exception addressed

Watch for

  • Selected term not established by the headline
  • Refunds can close at payment
  • Testing scope and deduction values unclear
Buy here if
A buyer who will obtain the complete selected-term invoice and understand medical-disqualification deductions before authorizing the subscription.
Look elsewhere if
A buyer expecting cancel-anytime wording to refund unused prepaid service or assuming all outside testing is covered.

Price it elsewhere

Other sellers that publish a matching price. Sellers we have reviewed come first, then sellers we have only priced; each group runs lowest price first.

FAQ

3 questions

Does timely cancellation refund the paid term?

The policy says cancellation stops future renewal without refunding the current term, so unused time should not be treated as an automatic refund.

Is medical disqualification always a complete refund?

The medical-disqualification exception can deduct used services under the policy, making the purchased components and their assigned values important to clarify before payment.

Does the FDA warning establish every order is defective?

The cited FDA record addresses specific marketing and labeling representations, without establishing that every order is defective or that a particular patient received affected medicine.

Price it at altRx

Every figure above was read from altRx’s own pages. The current one is a click away.

Questions the research answers

Other sellers we have priced

Nex Gen Health Rx$57.32/mo, Glutathione injection
Contour Health$60/mo, NAD+ injection
Collective$76/mo, Semaglutide injection
Avono Health$79/mo, Semaglutide injection
Lean Meds$79/mo, Semaglutide injection
RxPepsDirect$80 per vial, Sermorelin injection
Enhanced$89/mo, Semaglutide injection
Citizen Meds$91/mo, NAD+ injection

See all 459 sellers we have priced

Where every figure comes from

  1. Current semaglutide route, figures, evidence and pharmacy FAQ
  2. Current tirzepatide route and figure
  3. OpenLoop and bundled financial roles
  4. Clinical consent and outcome-data disclosure
  5. Payment finality, notice and exception terms
  6. Direct June8,2026 FDA warning and precise findings